BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 29363585)

  • 1. Biased signaling by thyroid-stimulating hormone receptor-specific antibodies determines thyrocyte survival in autoimmunity.
    Morshed SA; Ma R; Latif R; Davies TF
    Sci Signal; 2018 Jan; 11(514):. PubMed ID: 29363585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How one TSH receptor antibody induces thyrocyte proliferation while another induces apoptosis.
    Morshed SA; Ma R; Latif R; Davies TF
    J Autoimmun; 2013 Dec; 47():17-24. PubMed ID: 23958398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutral antibodies to the TSH receptor are present in Graves' disease and regulate selective signaling cascades.
    Morshed SA; Ando T; Latif R; Davies TF
    Endocrinology; 2010 Nov; 151(11):5537-49. PubMed ID: 20844004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TSH receptor autoantibodies.
    Michalek K; Morshed SA; Latif R; Davies TF
    Autoimmun Rev; 2009 Dec; 9(2):113-6. PubMed ID: 19332151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of thyrotropin-receptor blocking antibodies on stimulating autoantibodies from patients with Graves' disease.
    Lenzner C; Morgenthaler NG
    Thyroid; 2003 Dec; 13(12):1153-61. PubMed ID: 14751037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PDGF enhances orbital fibroblast responses to TSHR stimulating autoantibodies in Graves' ophthalmopathy patients.
    van Steensel L; Hooijkaas H; Paridaens D; van den Bosch WA; Kuijpers RW; Drexhage HA; van Hagen PM; Dik WA
    J Clin Endocrinol Metab; 2012 Jun; 97(6):E944-53. PubMed ID: 22438231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cleavage Region Thyrotropin Receptor Antibodies Influence Thyroid Cell Survival
    Morshed SA; Ma R; Latif R; Davies TF
    Thyroid; 2019 Jul; 29(7):993-1002. PubMed ID: 31025602
    [No Abstract]   [Full Text] [Related]  

  • 8. Rescue of thyroid cells from antibody induced cell death via induction of autophagy.
    Morshed S; Latif R; Davies TF
    J Autoimmun; 2022 Jan; 126():102746. PubMed ID: 34801870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of thyrotropin receptor antibody-induced signaling cascades.
    Morshed SA; Latif R; Davies TF
    Endocrinology; 2009 Jan; 150(1):519-29. PubMed ID: 18719020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Gq Biased Small Molecule Active at the TSH Receptor.
    Latif R; Morshed SA; Ma R; Tokat B; Mezei M; Davies TF
    Front Endocrinol (Lausanne); 2020; 11():372. PubMed ID: 32676053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies to the thyrotropin receptor.
    Ando T; Davies TF
    Clin Dev Immunol; 2005 Jun; 12(2):137-43. PubMed ID: 16050145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TSH receptor antibodies.
    Smith BR; Sanders J; Furmaniak J
    Thyroid; 2007 Oct; 17(10):923-38. PubMed ID: 17900238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyrotropin, but Not Thyroid-Stimulating Antibodies, Induces Biphasic Regulation of Gene Expression in Human Thyrocytes.
    Jang D; Morgan SJ; Klubo-Gwiezdzinska J; Banga JP; Neumann S; Gershengorn MC
    Thyroid; 2020 Feb; 30(2):270-276. PubMed ID: 31805824
    [No Abstract]   [Full Text] [Related]  

  • 14. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay.
    Morgenthaler NG; Hodak K; Seissler J; Steinbrenner H; Pampel I; Gupta M; McGregor AM; Scherbaum WA; Banga JP
    Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The thyroid-stimulating hormone receptor: impact of thyroid-stimulating hormone and thyroid-stimulating hormone receptor antibodies on multimerization, cleavage, and signaling.
    Latif R; Morshed SA; Zaidi M; Davies TF
    Endocrinol Metab Clin North Am; 2009 Jun; 38(2):319-41, viii. PubMed ID: 19328414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graves' Disease Mechanisms: The Role of Stimulating, Blocking, and Cleavage Region TSH Receptor Antibodies.
    Morshed SA; Davies TF
    Horm Metab Res; 2015 Sep; 47(10):727-34. PubMed ID: 26361259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal responses to neutral TSH receptor antibody - A cycle of damage in the pathophysiology of Graves' disease.
    Morshed S; Latif R; Davies TF
    J Autoimmun; 2023 Apr; 136():103012. PubMed ID: 36898184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyrotropin receptor antibodies: new insights into their actions and clinical relevance.
    Ando T; Latif R; Davies TF
    Best Pract Res Clin Endocrinol Metab; 2005 Mar; 19(1):33-52. PubMed ID: 15826921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of recombinant monoclonal antithyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves' disease: epitope and binding study of two stimulatory TSHRAbs.
    Akamizu T; Moriyama K; Miura M; Saijo M; Matsuda F; Nakao K
    Endocrinology; 1999 Apr; 140(4):1594-601. PubMed ID: 10098493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that TSH Receptor A-Subunit Multimers, Not Monomers, Drive Antibody Affinity Maturation in Graves' Disease.
    Rapoport B; Aliesky HA; Chen CR; McLachlan SM
    J Clin Endocrinol Metab; 2015 Jun; 100(6):E871-5. PubMed ID: 25856215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.